BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230724
DTEND;VALUE=DATE:20230729
DTSTAMP:20230421T161848Z
CREATED:20230421T161759Z
LAST-MODIFIED:20230421T161848Z
UID:56962-1690156800-1690588799@globalbiodefense.com
SUMMARY:Just Breathe: ARDS Therapeutics Pitch Event
DESCRIPTION:A BARDA-Sponsored Phase 2 ARDS Platform Clinical Trial \nBARDA will host ‘Just Breathe – An ARDS Therapeutics Pitch Event’ on July 24-28\, 2023 to support development of threat-agnostic and host-directed therapeutic candidates to address acute respiratory distress syndrome (ARDS). The event will be held in a virtual format. \nThe Biomedical Advanced Research and Development Authority Influenza & Emerging Infectious Diseases Division plans to support a randomized\, double-blinded\, placebo-controlled\, multi-center U.S. Phase 2 platform clinical trial that investigates multiple immune modulators or other host-directed therapeutics in hospitalized adult patients with acute respiratory distress syndrome (ARDS). In this trial\, BARDA will evaluate the safety and efficacy of novel threat-agnostic and host-directed therapeutics that could address ARDS caused by known or unknown health security threats such as pandemic influenza\, COVID-19\, other emerging infectious diseases\, and chemical\, biological\, radiological\, and nuclear (CBRN) incidents. \nMore information about the design of the phase 2 ARDS platform clinical trial is available in the draft protocol synopsis under the BAA Area of Interest (AOI) 9.7 (closed March 14\, 2023). \nTo participate in the Just Breathe Pitch Event\, drug sponsors will need to submit the following: \n\nSlide deck containing the required information about the proposed therapeutic candidate\nA current Investigator’s Brochure (IB) for the proposed therapeutic candidate\nSubmission cover page form\n\nInterested drug sponsors will have the opportunity to submit questions and receive feedback from BARDA on their initial slide deck submissions for revision and submit the updated slide deck for for the event. \nThe final (revised) slide deck submission and the IB will be evaluated by a scientific review process based on pre-specified criteria outlined in the presentation template. Drug sponsors with most competitive submissions will be invited to present virtually about their products and attend a live Q&A in front of an interagency review panel. \nUp to three phase 2-ready therapeutic candidates representing different mechanisms of action will be selected for inclusion in the planned BARDA-sponsored phase 2 ARDS platform clinical trial. \nPlease visit BARDA’s Influenza & Emerging Infectious Diseases Division website for additional program information and visit the Just Breathe – An ARDS Therapeutics Pitch Event page for submission instructions\, provided templates\, evaluation criteria\, and a detailed timeline. All pre-submission inquiries and submissions should be submitted to IEIDD_Tx@hhs.gov. Critical due dates for this pitch event are listed below: \n\nFinal day to submit questions: May 26\, 2023\, by 5 p.m. EDT\nInitial slide deck submission: June 2\, 2023\, by 5 p.m. EDT\nFinal (revised) slide deck submission: June 30\, 2023\, by 5 p.m. EDT\nPitch event presentation invitations to drug sponsors with the most competitive therapeutic candidates: July 10\, 2023\nJust Breathe – An ARDS Therapeutics Pitch Event: July 24-28\, 2023\n\nSource: Biomedical Advanced Research and Development Authority
URL:https://globalbiodefense.com/event/just-breathe-ards-therapeutics-pitch-event/
CATEGORIES:Government Hosted,Industry Day,Innovation Challenge
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2023/04/barda-just-breathe-ards-clinical-trial-therapeutics.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200321T100000
DTEND;TZID=America/Toronto:20200321T180000
DTSTAMP:20200203T162942Z
CREATED:20200203T162408Z
LAST-MODIFIED:20200203T162942Z
UID:38416-1584784800-1584813600@globalbiodefense.com
SUMMARY:University of Toronto Global Health & AI Challenge
DESCRIPTION:HOW WILL YOU AND YOUR TEAM USE AI TO SOLVE SOME OF THE MOST COMPLEX GLOBAL HEALTH CHALLENGES\n\n\n\nThe Global Health & AI Challenge\, a partnership between the Dalla Lana School of Public Health and Vector Institute will engage students in critical dialogue and problem-solving scenarios on some of the most complex global health challenges of our time. The top ten threats to global health in 2019 include the climate crisis and air pollution; noncommunicable diseases; an impending influenza pandemic; fragile settings; antimicrobial resistance; high-threat pathogens; inadequate primary health care; vaccine hesitancy; the growing threat of dengue; and the HIV epidemic . All threats to global health exist due to complex\, interrelated economic\, political\, social\, environmental\, and historical factors\, and thus demand creative\, interdisciplinary and intersectoral solutions. Technological innovations and interventions such as AI offer the potential to disrupt these complex threats\, and teams will be tasked with developing solutions that harness the power of AI and machine learning. \n***REGISTRATION DEADLINE IS DECEMBER 8TH\, 2019. SPOTS ARE LIMITED*** \nGlobal Health & AI Challenge Objectives \n\nOffer students local\, accessible experiential and entrepreneurial learning opportunities in global health\nEnhance student learning outcomes around ethical design thinking\, communication\, problem solving\, innovation\, and applying technical skills and AI\nExpand students’ knowledge of the complexity of global health threats and the application of AI-related methodologies and their limitations\nFacilitate student networking and career exploration opportunities\n\nWhat to expect? \n\nJoin a multi-disciplinary team of students to select and tackle a global health challenge.\nApply principles of ethical design thinking to prototype solutions using AI and machine learning.\nAccess an expert team advisor for additional mentorship and guidance.\nCompete to win a team prize of a $500 honorarium\, the opportunity to present your solution to relevant stakeholders (may include investment partners\, organizations or leading experts)\, $100 gift cards to App Store and iTunes\n\nWho can participate? \nThe Global Health & AI Challenge will be open only to current University of Toronto graduate students. Students will be able to sign up individually or in pairs and will then be matched up with students from other programs to ensure teams are multidisciplinary. \nTeams must include at least one student studying in each of the following programs: \n\nDalla Lana School of Public Health (DLSPH)\, including Public Health Sciences & IHPME\nSTEM programs such as Computer Science and Engineering\nRotman School of Management\n\nGraduate students pursuing other programs of study are also encouraged to apply along with a brief statement of interest of no more than 250 words. The optimal number of multidisciplinary teams for this year will be between 6-10\, with 4-6 participants on each team. Students will be able to sign up individually or in pairs and will then be matched up with students from other programs to ensure teams are multidisciplinary. There will be a $25 fee for each student to sign up. \n***REGISTRATION DEADLINE IS DECEMBER 8TH\, 2019. SPOTS ARE LIMITED*** \nTimeline \n\nDecember 8th – deadline for students to apply as individuals or in pairs\nDecember 16th – during this week participating students will be invited to a kickoff introduction event to meet their teammates from other programs.\nJanuary 12th – Teams will submit their initial global health problem identification proposal\nMid January/Early February – Teams will be invited to professional development workshops focused on global health & AI\, design thinking and ethics to apply to their own global health challenge\nFebruary – Each team will be assigned expert team advisor to meet with to provide additional mentorship and guidance.\nMarch 21st – All teams will present their global health challenge and solutions to a panel of judges and stakeholders.\n\nFor more information please contact ghoffice.dlsph@utoronto.ca \n#GHAIChallenge #GlobalHealthDLSPH #VectorInst
URL:https://globalbiodefense.com/event/university-of-toronto-global-health-ai-challenge/
LOCATION:Health Sciences Building\, 155 College Street\, Room 507\, TORONTO\, ON\, M5T 3M7\, Canada
CATEGORIES:Innovation Challenge
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/0299fad3c83db38250c5b87494431a50.jpg
END:VEVENT
END:VCALENDAR